Harpreet S. Dhaliwal - 02 Mar 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: SVP Cml Mfg & Supply Chain
Signature: /s/ Ron Metzger, Attorney-in-Fact
Issuer symbol: PCVX
Transactions as of: 02 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2022, 19:54:30 UTC
Previous filing: 01 Feb 2022
Next filing: 07 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Award	$0	+17,500		$0.000000	17,500	02 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Award	$0	+45,000		$0.000000	45,000	02 Mar 2022	Common Stock	45,000	$24.79	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
F2	1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.